1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: MRNA Synthesis Raw Materials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. MRNA Synthesis Raw Materials Market Revenue and Volume Forecast, by Product Type
8.1.1. Enzymes
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. RNA polymerases
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. DNases
8.1.3.1. Market Revenue and Volume Forecast
8.1.3. RNases inhibitors
8.1.3.1. Market Revenue and Volume Forecast
8.1.3. Nucleotides (NTPs / modified nucleotides)
8.1.3.1. Market Revenue and Volume Forecast
8.1.3. Capping Reagents & Analogues
8.1.3.1. Market Revenue and Volume Forecast
8.1.3. DNA Templates & Plasmids
8.1.3.1. Market Revenue and Volume Forecast
8.1.3. Other Reagents & Consumables
8.1.3.1. Market Revenue and Volume Forecast
9.1. MRNA Synthesis Raw Materials Market Revenue and Volume Forecast, by Raw Material Grade
9.1.1. GMP-grade Raw Materials
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Research-use-only (RUO) Grade
9.1.2.1. Market Revenue and Volume Forecast
10.1. MRNA Synthesis Raw Materials Market Revenue and Volume Forecast, by Application
10.1.1. mRNA Vaccines
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. mRNA Therapeutics
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. mRNA Research & Preclinical Development
10.1.3.1. Market Revenue and Volume Forecast
11.1. MRNA Synthesis Raw Materials Market Revenue and Volume Forecast, by End-User
11.1.1. Biopharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Academic & Research Institutes
11.1.3.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Raw Material Grade
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End-User
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerProduct Typeance
13.1.4. Recent Initiatives
13.2. Merck KGaA (including MilliporeSigma)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerProduct Typeance
13.2.4. Recent Initiatives
13.3. Maravai LifeSciences (primarily through TriLink BioTechnologies)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProduct Typeance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProduct Typeance
13.4.4. Recent Initiatives
13.5. New England Biolabs (NEB)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProduct Typeance
13.5.4. Recent Initiatives
13.6. Jena Bioscience GmbH
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProduct Typeance
13.6.4. Recent Initiatives
13.7. Yeasen Biotechnology (Shanghai) Co., Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProduct Typeance
13.7.4. Recent Initiatives
13.8. BOC Sciences
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProduct Typeance
13.8.4. Recent Initiatives
13.9. Promega Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProduct Typeance
13.9.4. Recent Initiatives
13.10. HONGENE
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProduct Typeance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
